BRVE — BRAVEHEART BIO INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BRVE?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their BRVE position last quarter, 2 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 45/100 in a Overheat regime).
- +2 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin)
- +2 tracked investors reported holding BRVE at their latest filing
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/17/2026.
About BRAVEHEART BIO INC (BRVE)
BRAVEHEART BIO INC (BRVE) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $2M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BRVE
How many top investors track BRVE
Only 2 tracked investors report this position.
BRVE Ownership Composition
How BRAVEHEART BIO INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting BRVE
- Izzy EnglanderSep 30, 2026Millennium ManagementShares115KValue$2.3M% Portfolio0.00%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares51.6KValue$1M% Portfolio0.00%
Recent activity
- $2.3MNov 16, 2026
- New$1MNov 16, 2026
Frequently asked questions
- How many institutional investors hold BRVE?
- 2 tracked institutional investors disclosed a position in BRVE (BRAVEHEART BIO INC) in their most recent 13F filing.
- Who is the largest institutional holder of BRVE?
- Izzy Englander, Millennium Management, holds the largest disclosed position in BRVE, valued at $2M.
- Did institutional ownership of BRVE increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited BRVE.
- Where does this BRVE ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.